Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma

Silviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, Mabrouka Doghman-Bouguerra, Esther Korpershoek, Ronald R. de Krijger, Hester Ettaieb, Harm Haak, Marco Volante, Mauro Papotti, Giuseppe Reimondo, Massimo Terzolo, Michaela Luconi, Gabriella Nesi, Massimo Mannelli, Rossella Libe, Bruno Ragazzon, Guillaume Assie, Jerome Bertherat, Barbara AltieriGuido Fadda, Natalie Rogowski-Lehmann, Martin Reincke, Felix Beuschlein, Martin Fassnacht, Enzo Lalli

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3491-3498
Number of pages8
JournalJournal of Clinical Endocrinology & Metabolism
Volume102
Issue number9
DOIs
Publication statusPublished - Sep 2017

Keywords

  • GENE-EXPRESSION
  • GENOMIC CHARACTERIZATION
  • HELSINKI SCORE
  • TUMORS
  • CANCER
  • PROLIFERATION
  • MARKER
  • CLASSIFICATION
  • VALIDATION
  • RECURRENCE

Cite this

Sbiera, S., Sbiera, I., Ruggiero, C., Doghman-Bouguerra, M., Korpershoek, E., de Krijger, R. R., Ettaieb, H., Haak, H., Volante, M., Papotti, M., Reimondo, G., Terzolo, M., Luconi, M., Nesi, G., Mannelli, M., Libe, R., Ragazzon, B., Assie, G., Bertherat, J., ... Lalli, E. (2017). Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. Journal of Clinical Endocrinology & Metabolism, 102(9), 3491-3498. https://doi.org/10.1210/jc.2017-00984